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We report two hypertensive females, one suffering from chronic renal failure and on regular dialysis, the other with eclamp-
sia. Both developed new onset seizures. The patients’ MRI of brain showed signals consistent with the reversible posterior
leukoencephalopathy syndrome (RPLES), but with the signals seen only in the hemisphere where the seizures predominated.
The anatomic correlation of the clinical and imaging findings supports the notion that seizures have a major role in the genesis
and evolution of RPLES.
© 2003 BEA Trading Ltd. Published by Elsevier Ltd. All rights reserved.
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INTRODUCTION
Reversible posterior leukoencephalopathy syndrome
(RPLES) is a recently described entity, which clini-
cally manifests with headache, nausea, vomiting, dis-
turbed level of consciousness, seizures, visual distur-
bances, and occasionally focal neurologic deficits7.
The hallmark of this syndrome is the presence of
reversible lesions, best visualised with T2-weighted
MRI imaging especially on FLAIR sequencing. This
mainly involves the posterior regions of the brain and
is most prominent in the white matter although grey
matter may be affected also6, 7. These lesions are most
likely vasogenic oedema and are usually bilateral. The
syndrome is commonly described in hypertensive en-
cephalopathy, eclampsia, renal failure and in patients
on immunosuppressive therapy6, 7. An abrupt rise of
blood pressure (BP) is incriminated as the main factor
in the pathogenesis of this syndrome, although it has
been described in absence of severe hypertension6, 7.
Some authors believe that the encephalopathy is, in
fact, a seizure-related phenomenon in a brain whose
autoregulatory mechanisms are impaired. Hence, it is
speculated that RPLES is not a specific syndrome or
disease11, 12. The purpose of our report is to describe
two atypical cases that, we believe, illustrate the sig-
nificant role seizures have in this syndrome.
PATIENT 1
A 50-year female patient with chronic renal failure on
regular haemodialysis was admitted to King Abdulaziz
Medical City (KAAMC), Jeddah, with a disturbed
level of consciousness and seizures. The family found
the patient in a drowsy state with occasional left-sided
motor seizures onset after her dialysis. There was no
history of previous seizures. When seen in the Emer-
gency Department, she was drowsy with normal vital
signs except for BP of 150/95 mmHg and a left-sided
flaccid hemiplegia. She was treated with i.v. diazepam
and phenytoin, following which her level of conscious-
ness improved dramatically although the hemiplegia
persisted. FBC, including RBC morphology and co-
agulation profile, were normal apart from a Hb of
9.8 g/dl. Biochemistry results were normal except for
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Fig. 1: (a) FLAIR imaging showing high signal intensity lesions in the right posterior parietal area. (b) Disappearance of the
signals 6 days later.
a glucose of 13.4 mm/l. The ECG and echocardiogram
showed evidence of left ventricular hypertrophy only.
Screening for infection, including CSF examination,
was negative. The EEG done 24 hours after admission
showed generalised theta activity more prominent on
the right side while the admission CT scan of the brain
was normal. The MRI which was performed 48 hours
later showed high signal intensity lesions in the right
parietal region on T2 images, best visualised with
FLAIR (Fig. 1(a)). The lesions were non-enhancing
and the concomitant MRA was normal. The hemiple-
gia resolved within 48 hours and a repeat MRI of the
brain 6 days later was normal (Fig. 1(b)). Phenytoin
therapy was discontinued after 4 weeks and over a
follow-up period of 8 months she remained well.
PATIENT 2
A 36 years old woman, gravida VII, in the 37th week
of gestation was admitted to KAAMC with an an-
tepartum uterine haemorrhage. She was found to have
a BP of 170/98 mmHg, oedema of the legs and pro-
teinuria. She was diagnosed as having pre-eclamptic
toxaemia with placenta previa. Treatment was started
with magnesium sulphate and captopril and the patient
was booked for an urgent Caesarean section (CS).
Three hours later the patient complained of a severe
headache and had visual hallucinations. She then had
a generalised tonic–clonic seizure lasting less than a
minute and was treated with i.v. diazepam. There was
no prior history of seizures. Investigations were as
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Fig. 2: (a) FLAIR imaging showing high signal intensity lesions in the occipital and parietal area. (b) FLAIR images showing
resolution of the signals 3 weeks later.
follows: a normal FBC, including RBC morphology
and coagulation profile, apart from Hb of 10.2 g/dl.
The biochemical screening was normal except for an
albumin of 25 g/dl (N = 34–48) and mildly elevated
liver enzymes. Autoimmune and hepatitis screens
were negative.
An emergency CS was performed. Postoperatively,
she continued to complain of headaches and visual
blurring. She subsequently had six, right-sided partial
motor seizures all lasting less than 10 minutes, follow-
ing which the patient was given 1.5 g of i.v. phenytoin.
At that time a bedside visual field assessment was
normal, her reflexes were brisk with power of grade
4 (MRC grading) and a Babinski’s sign on the right.
The BP increased to 180/110 mmHg and was treated
with captopril and hydralazine. The CT scan of brain
showed a hypodense area in left parieto-occipital
region. An MRI of the brain performed 48 hours
later showed signals on the T2-weighted images and
FLAIR in the right parieto-occipital region which
was non-enhancing (Fig. 2(a)). A concomitant MRA
was normal. The postictal EEG showed increased
theta/delta activity in the left hemisphere with no
epileptogenic foci. The neurological findings resolved
in 5 days although she complained of visual blurring
which lasted for 2 weeks. A repeat MRI 10 days later
showed reduction in the size of the signals and had
normalised 3 weeks later (Fig. 2(b)). The patient’s
phenytoin was stopped after 3 weeks and she re-
ported no further seizures over a follow-up period of
6 months.
DISCUSSION
These two cases qualify for the diagnosis of RPLES,
as they both had the etiologic, clinical and radiological
features of RPLES. Other diagnostic considerations,
such as ischemic stroke, sinus thrombosis, infection
and autoimmune diseases, are unlikely because of the
clinical course and lack of supportive evidence. What
is unusual is the fact that the transient signal changes
280 T. Obeid et al.
were unilateral, which makes our cases formes fruste
of RPLES. The unilaterality of the MRI high signal
intensity lesions corresponding to the side of the brain
where the convulsive activity appears to have domi-
nated, suggests that seizures must have a major role
in the evolution of these MRI lesions. One may argue
that the MRI signals in these cases are the well-known
transient seizure-related shadows well described in the
literature1, 3–5, 8–10, 13–15. It is interesting to note that
in reviewing such cases, the lesions are usually seen
only in protracted partial status epilepticus. These two
cases had no history of epilepsy and their seizures were
short-lived. The previously described shadows in sta-
tus epilepticus whether partial or generalised differ in
many aspects from the MRI signal changes described
in RPLES and seen in these two cases. With status
the signals are usually cortical although subcortical
extension may occur3–5, 8–10, 13. Not infrequently they
are associated with swelling of the gyri with a mass
effect3–5, 8, 10, 13. As well, they are usually seen in the
maximally discharging regions as documented in func-
tional MRI, SPECT and video-EEG studies1, 4, 5, 8, 10.
There is a suggestion that the changes in the grey
matter result from hypoxia or release of excitatory
amines4.
In the majority of RPLES cases tonic–clonic or oc-
cipital lobe seizures precede the other manifestations
of the syndrome, although status epilepticus is not
described2, 7, 14. Some authors believe that in patients
with RPLES, as in these two cases, the seizures,
which are not protracted, cause unilateral vasogenic
oedema in vulnerable regions of the brain11, 12. These
are usually the posterior regions where the paucity of
sympathetic innervation of this region is hypothesised
to predispose to this vulnerability2. Most RPLES
patients have severe metabolic abnormalities which
are believed to disturb the integrity of distal brain
vascularity or interfere with sympathetic activity,
leading to a breakdown of the blood–brain barrier
(BBB)6, 7. The abrupt rise of BP relative to baseline
may play a major role in disrupting this autoregulatory
mechanism6. Seizures themselves may contribute to
an abrupt rise in BP. There are as yet no prospective
studies of RPLES making under reporting of seizures
a real possibility. This is especially so in the situation
when RPLES patients have associated serious medical
problems which may make subtle seizures difficult to
recognise. The lack of enhancement on MRI in these
two patients suggests that the breakdown of BBB was
transient as the imaging was done 2 days after the
ictus. The magnitude and extent of the lesions depend
mainly on the water content of the brain as well as the
type and severity of seizures. Occipital lobe seizures
have been described as a major clinical manifesta-
tion of RPLES2–14. This suggests that occipital lobe
seizures may play a significant role in the anatomical
location of the signal changes, offering an alternative
explanation for the posterior location of the lesions
instead of the hypothesis that a paucity of sympa-
thetic innervation in that region is the reason for this
location2.
The abrupt development of RPLES and its quick re-
sponse to the lowering of BP and control of seizures,
despite of the signal changes outlasting the clinical
features of the syndrome by several days or weeks,
imply that the shadows have no significant role in
the symptology of the syndrome except for the visual
disturbances. Shortcomings of these case studies in-
clude a lack of utilisation of DWI, functional MRI
and video-EEG monitoring. Despite these limitations
the anatomic correlation of the clinical and imaging
finding supports the notion that seizures play a ma-
jor significant role in the genesis and evolution of
RPLES11.
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